Monday, June 22, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 233 of 1,261
  1. US 11472789

    Bicyclic carboxamides and methods of use thereof

    TEMPEST THERAPEUTICS, INC. · Granted Oct 18, 2022 · Expires Oct 13, 2042

    granted
  2. US 11471471

    Aqueous oral pharmaceutical suspension compositions

    ReveraGen BioPharma, Inc. · Granted Oct 18, 2022 · Expires Oct 13, 2042

    granted
  3. US 11472782

    RIP1 inhibitory compounds and methods for making and using the same

    Rigel Pharmaceuticals, Inc. · Granted Oct 18, 2022 · Expires Oct 13, 2042

    granted
  4. US 11472813

    OX2R compounds

    The Board of Regents of the University of Texas System · Granted Oct 18, 2022 · Expires Oct 13, 2042

    granted
  5. US 11472842

    Analogues of hepcidin mimetics with improved in vivo half lives

    Protagonist Therapeutics, Inc. · Granted Oct 18, 2022 · Expires Oct 13, 2042

    granted
  6. US 11472804

    Compositions and methods for modulating hair growth

    The Regents of the University of California · Granted Oct 18, 2022 · Expires Oct 13, 2042

    granted
  7. US 11472812

    Anti-cancer compounds targeting Ral GTPases and methods of using the same

    The Regents of the University of Colorado, a Body Corporate · Granted Oct 18, 2022 · Expires Oct 13, 2042

    granted
  8. US 11472861

    Methods for producing aflibercept in chemically defined media having reduced aflibercept variants

    REGENERON PHARMACEUTICALS, INC. · Granted Oct 18, 2022 · Expires Oct 13, 2042

    granted
  9. US 11470861

    Preparation method and application of astaxanthin H1-, or H2- or J-aggregate water dispersion system

    OCEAN UNIVERSITY OF CHINA · Granted Oct 18, 2022 · Expires Oct 13, 2042

    granted
  10. US 11471491

    Materials and methods for engineering cells and uses thereof in immuno-oncology

    CRISPR THERAPEUTICS AG · Granted Oct 18, 2022 · Expires Oct 13, 2042

    granted
  11. US 11471517

    Compositions and methods for preventing and treating graft versus host disease

    Regents of the University of Minnesota · Granted Oct 18, 2022 · Expires Oct 13, 2042

    granted
  12. US 11464856

    Combination therapy using inhibitors of human growth and differentiation factor 15 (GDF-15) and immune checkpoint blockers

    Julius-Maximilians-Universitat Wurzburg · Granted Oct 11, 2022 · Expires Oct 6, 2042

    granted
  13. US 11464830

    Treatment of inflammatory conditions by delivery of interleukin-1 receptor antagonist fusion protein

    REGENERON PHARMACEUTICALS, INC. · Granted Oct 11, 2022 · Expires Oct 6, 2042

    granted
  14. US 11466071

    HLA class I-restricted t cell receptors against mutated RAS

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 11, 2022 · Expires Oct 6, 2042

    granted
  15. US 11464788

    Oligomer-corticosteroid conjugates

    Nektar Therapeutics · Granted Oct 11, 2022 · Expires Oct 6, 2042

    granted
  16. US 11464841

    TERT immunogenic compositions and methods of treatment using the same

    Inovio Pharmaceuticals, Inc. · Granted Oct 11, 2022 · Expires Oct 6, 2042

    granted
  17. US 11465993

    Water soluble novel cyanine fluorophore with tunable properties between near IR and SWIR region for in vivo imaging

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 11, 2022 · Expires Oct 6, 2042

    granted
  18. US 11464812

    Synergistic bacterial compositions and methods of production and use thereof

    Seres Therapeutics, Inc. · Granted Oct 11, 2022 · Expires Oct 6, 2042

    granted
  19. US 11464807

    Genetically engineered hematopoietic stem cells and uses thereof

    Vor Biopharma Inc. · Granted Oct 11, 2022 · Expires Oct 6, 2042

    granted
  20. US 11464802

    3-substituted piperidine compounds for Cbl-b inhibition, and use thereof

    NURIX THERAPEUTICS, INC. · Granted Oct 11, 2022 · Expires Oct 6, 2042

    granted
  21. US 11464801

    Compositions and methods for treating cancer with anti-CD33 immunotherapy

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 11, 2022 · Expires Oct 6, 2042

    granted
  22. US 11464843

    Use of the salmonella SPP type III secretion proteins as a protective vaccination

    The Board of Regents for Oklahoma State University · Granted Oct 11, 2022 · Expires Oct 6, 2042

    granted
  23. US 11464869

    Non-adult human dosing of brentuximab vedotin

    Takeda Pharmaceutical Company Limited · Granted Oct 11, 2022 · Expires Oct 6, 2042

    granted
  24. US 11464845

    Neisseria meningitidis immunogenic compositions

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 11, 2022 · Expires Oct 6, 2042

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.